CLINICAL CHARACTERISTICS OF PATIENTS WITH TRANSTHYRETIN GENE MUTATIONS AND POLYNEUROPATHY MANIFESTATIONS OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS

被引:0
|
作者
Khella, Sami
Shah, Keyur
Delgado, Diego
Marti, Catherine
Keller, Andrew
Jefferies, John
Towne, Meghan
Gabriel, Aaron
Narayana, Arvind
Olugemo, Kemi
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
118
引用
收藏
页码:S67 / S67
页数:1
相关论文
共 50 条
  • [21] EFFICACY OF INOTERSEN FOR NEUROPATHIC IMPAIRMENT SCORES IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY
    Yarlas, Aaron
    Lovley, Andrew
    Brown, Duncan
    Llonch, Montserrat Vera
    Karam, Chafic
    Khella, Sami
    [J]. MUSCLE & NERVE, 2021, 64 : S61 - S61
  • [22] The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy
    Yarlas, Aaron
    Lovley, Andrew
    Brown, Duncan
    Vera-Llonch, Montserrat
    Khella, Sami
    Karam, Chafic
    [J]. BMC NEUROLOGY, 2023, 23 (01)
  • [23] Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
    Kollmer, Jennifer
    Hegenbart, Ute
    Kimmich, Christoph
    Hund, Ernst
    Purrucker, Jan C.
    Hayes, John M.
    Lentz, Stephen, I
    Sam, Georges
    Jende, Johann M. E.
    Schoenland, Stefan O.
    Bendszus, Martin
    Heiland, Sabine
    Weiler, Markus
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (05): : 799 - 807
  • [24] Hereditary transthyretin amyloidosis
    Hund, E.
    [J]. NERVENARZT, 2014, 85 (10): : 1291 - 1297
  • [25] Corneal Nerve Fiber Length In Hereditary Transthyretin Amyloidosis Polyneuropathy
    Alcantara, Monica
    Mannan, Shabber
    Perkins, Bruce
    Bril, Vera
    [J]. NEUROLOGY, 2020, 94 (15)
  • [26] Inotersen to Treat Polyneuropathy Associated with Hereditary Transthyretin (hATTR) Amyloidosis
    Robinson, Christopher
    Pham, Cynthia
    Zamarripa, Alec M.
    Dugay, Chase S.
    Lee, Christopher A.
    Berger, Amnon A.
    Landman, Avi
    Cornett, Elyse M.
    Kassem, Hisham
    Kaye, Alan D.
    Urits, Ivan
    Viswanath, Omar
    Ganti, Latha
    [J]. HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (05):
  • [27] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    [J]. Drugs, 2023, 83 : 1425 - 1432
  • [28] Treatment characteristics of patients with hereditary transthyretin amyloidosis: a cohort study
    Qarni, Taha N.
    Jones, Felipe J. S.
    Drachman, Brian
    Khella, Sami
    Pieretti, Janice
    Bustamante, Nicolas Sarmiento
    Karam, Chafic
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [29] Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin
    Jercan, Andreea
    Badelita, Sorina
    Draghici, Mirela
    Stoica, Emanuel
    Iacob, Speranta
    Coriu, Daniel
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 31 - 32
  • [30] Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
    Adams, David
    Tournev, Ivailo L.
    Taylor, Mark S.
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian D.
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Chen, Chongshu
    Badri, Prajakta
    Arum, Seth M.
    Vest, John
    Polydefkis, Michael
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2023, 30 (01): : 18 - 26